Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Mallinckrodt
UBS
Julphar
Healthtrust
Accenture
Chinese Patent Office
Moodys
Medtronic

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040407

« Back to Dashboard
NDA 040407 describes PROCHLORPERAZINE, which is a drug marketed by Able, Alpharma Us Pharms, G And W Labs, Baxter Hlthcare, Watson Labs, Hospira, West-ward Pharms Int, Teva Parenteral, Athenex Inc, Emcure Pharms Ltd, Wyeth Ayerst, Smith And Nephew, Marsam Pharms Llc, Morton Grove, Sandoz, Duramed Pharms Barr, Teva Pharms, Ivax Sub Teva Pharms, and Mylan, and is included in thirty NDAs. It is available from four suppliers. Additional details are available on the PROCHLORPERAZINE profile page.

The generic ingredient in PROCHLORPERAZINE is prochlorperazine maleate. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.

Summary for NDA: 040407

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;RECTALStrength2.5MG
Approval Date:Jul 11, 2001TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;RECTALStrength5MG
Approval Date:Jul 11, 2001TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;RECTALStrength25MG
Approval Date:Jul 11, 2001TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
McKinsey
Queensland Health
Citi
US Army
Harvard Business School
Cerilliant
Deloitte
Cipla
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot